Cargando…
Histopathological Features of Methotrexate Induced Pulmonary Lesions in Rheumatoid Arthritis Patients: A Systematic Review of Case Reports
BACKGROUND: Methotrexate (MTX) is the most commonly used disease-modifying drug in the treatment of rheumatoid arthritis (RA); however, it causes many side effects, including pulmonary lesions. In this review, we characterised the histopathological features of MTX-induced pulmonary lesions in RA pat...
Autores principales: | Thaniyan, Anthony, Ayman, Foad F. A., Mirghani, Hyder O., Al-Sayed, Badr A., Merghani, Tarig H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
ID Design 2012/DOOEL Skopje
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420786/ https://www.ncbi.nlm.nih.gov/pubmed/28507640 http://dx.doi.org/10.3889/oamjms.2017.049 |
Ejemplares similares
-
Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis
por: Salem, Heba F., et al.
Publicado: (2022) -
Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
por: Rexhepi, Sylejman, et al.
Publicado: (2012) -
Methotrexate Hepatotoxicity in Patients with Rheumatoid Arthritis
por: Sotoudehmanesh, R, et al.
Publicado: (2010) -
Adherence to Methotrexate therapy in Rheumatoid Arthritis
por: Arshad, Nasim, et al.
Publicado: (2016) -
Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis
por: Alunno, Alessia, et al.
Publicado: (2017)